204 related articles for article (PubMed ID: 9846166)
1. Effects of repeated doses and continuous infusions of the growth hormone-releasing peptide hexarelin in conscious male rats.
Conley LK; Gaillard RC; Giustina A; Brogan RS; Wehrenberg WB
J Endocrinol; 1998 Sep; 158(3):367-75. PubMed ID: 9846166
[TBL] [Abstract][Full Text] [Related]
2. Interaction of the growth hormone releasing peptide hexarelin with somatostatin.
Massoud AF; Hindmarsh PC; Brook CG
Clin Endocrinol (Oxf); 1997 Nov; 47(5):537-47. PubMed ID: 9425393
[TBL] [Abstract][Full Text] [Related]
3. The effects of a continuous infusion of hexarelin on pulsatile growth hormone release, growth axis and galanin gene expression and on the response of the growth axis to growth hormone-releasing hormone.
Conley LK; Brogan RS; Giustina A; Wehrenberg WB
Pituitary; 2000 May; 2(4):253-60. PubMed ID: 11081146
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of action of hexarelin and GHRP-6: analysis of the involvement of GHRH and somatostatin in the rat.
Conley LK; Teik JA; Deghenghi R; Imbimbo BP; Giustina A; Locatelli V; Wehrenberg WB
Neuroendocrinology; 1995 Jan; 61(1):44-50. PubMed ID: 7731497
[TBL] [Abstract][Full Text] [Related]
5. Twenty-four-hour growth hormone (GH)-releasing peptide (GHRP) infusion enhances pulsatile GH secretion and specifically attenuates the response to a subsequent GHRP bolus.
Huhn WC; Hartman ML; Pezzoli SS; Thorner MO
J Clin Endocrinol Metab; 1993 May; 76(5):1202-8. PubMed ID: 8496311
[TBL] [Abstract][Full Text] [Related]
6. Acute administration of hexarelin stimulates GH secretion during day and night in normal men.
Loche S; Colao A; Cappa M; Ferone D; Merola B; Faedda A; Imbimbo BP; Deghenghi R; Lombardi G
Clin Endocrinol (Oxf); 1997 Mar; 46(3):275-9. PubMed ID: 9156035
[TBL] [Abstract][Full Text] [Related]
7. The effect of repeated administration of hexarelin, a growth hormone releasing peptide, and growth hormone releasing hormone on growth hormone responsivity.
Massoud AF; Hindmarsh PC; Matthews DR; Brook CG
Clin Endocrinol (Oxf); 1996 May; 44(5):555-62. PubMed ID: 8762732
[TBL] [Abstract][Full Text] [Related]
8. Tripartite neuroendocrine activation of the human growth hormone (GH) axis in women by continuous 24-hour GH-releasing peptide infusion: pulsatile, entropic, and nyctohemeral mechanisms.
Shah N; Evans WS; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 1999 Jun; 84(6):2140-50. PubMed ID: 10372723
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man.
Ghigo E; Arvat E; Gianotti L; Imbimbo BP; Lenaerts V; Deghenghi R; Camanni F
J Clin Endocrinol Metab; 1994 Mar; 78(3):693-8. PubMed ID: 8126144
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide modulation of the growth hormone-releasing activity of Hexarelin in young and old dogs.
Rigamonti AE; Cella SG; Marazzi N; Müller EE
Metabolism; 1999 Feb; 48(2):176-82. PubMed ID: 10024078
[TBL] [Abstract][Full Text] [Related]
11. Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects.
Arvat E; Gianotti L; Grottoli S; Imbimbo BP; Lenaerts V; Deghenghi R; Camanni F; Ghigo E
J Clin Endocrinol Metab; 1994 Nov; 79(5):1440-3. PubMed ID: 7962341
[TBL] [Abstract][Full Text] [Related]
12. Abuse of recombinant human growth hormone: studies in two different dog models.
Rigamonti AE; Scanniffio D; Bonomo SM; Cella SG; Sartorio A; Müller EE
Neuroendocrinology; 2004; 79(5):237-46. PubMed ID: 15218318
[TBL] [Abstract][Full Text] [Related]
13. GH responsiveness to repeated GHRH or hexarelin administration in normal adults.
Sartorio A; Conti A; Ferrero S; Spada A; Faglia G
J Endocrinol Invest; 1995 Oct; 18(9):718-22. PubMed ID: 8719303
[TBL] [Abstract][Full Text] [Related]
14. Metabolic modulation of the growth hormone-releasing activity of hexarelin in man.
Maccario M; Arvat E; Procopio M; Gianotti L; Grottoli S; Imbimbo BP; Lenaerts V; Deghenghi R; Camanni F; Ghigo E
Metabolism; 1995 Jan; 44(1):134-8. PubMed ID: 7854159
[TBL] [Abstract][Full Text] [Related]
15. Effects of a prolonged growth hormone (GH)-releasing peptide infusion on pulsatile GH secretion in normal men.
Jaffe CA; Ho PJ; Demott-Friberg R; Bowers CY; Barkan AL
J Clin Endocrinol Metab; 1993 Dec; 77(6):1641-7. PubMed ID: 7903313
[TBL] [Abstract][Full Text] [Related]
16. Evidence for a primary involvement of somatostatin in clonidine-induced growth hormone release in conscious rats.
Lanzi R; Lapointe M; Gurd W; Tannenbaum GS
J Endocrinol; 1994 May; 141(2):259-66. PubMed ID: 7913948
[TBL] [Abstract][Full Text] [Related]
17. Hexarelin stimulation of growth hormone release and mRNA levels in an infant and adult rat model of impaired GHRH function.
Torsello A; Luoni M; Grilli R; Guidi M; Wehrenberg WB; Deghenghi R; Müller EE; Locatelli V
Neuroendocrinology; 1997 Feb; 65(2):91-7. PubMed ID: 9067986
[TBL] [Abstract][Full Text] [Related]
18. Effect of intravenous or intracerebroventricular injections of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 on GH release in conscious, freely moving male rats.
Yagi H; Kaji H; Sato M; Okimura Y; Chihara K
Neuroendocrinology; 1996 Feb; 63(2):198-206. PubMed ID: 9053785
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone-releasing hormone and somatostatin concentrations in the hypophysial portal blood of conscious sheep during the infusion of growth hormone-releasing peptide-6.
Fletcher TP; Thomas GB; Clarke IJ
Domest Anim Endocrinol; 1996 May; 13(3):251-8. PubMed ID: 8738866
[TBL] [Abstract][Full Text] [Related]
20. Hexarelin induced growth hormone release is influenced by exogenous growth hormone.
Massoud AF; Hindmarsh PC; Brook CG
Clin Endocrinol (Oxf); 1995 Nov; 43(5):617-21. PubMed ID: 8548947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
